214 results
8-K
EX-10.1
HBIO
Harvard Bioscience Inc.
3 Apr 24
Entry into a Material Definitive Agreement
8:01am
; and
WHEREAS, each Loan Party expects to realize substantial direct and indirect benefits as a result of this Amendment becoming effective, and agrees
8-K
HBIO
Harvard Bioscience Inc.
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
and the 2021 Incentive Plan. Receipt of the foregoing termination benefits will be subject to Ms. Cote’s execution of a separation agreement, including
8-K
EX-10.1
7023q o4iw7bkk3m9
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
EX-10.1
61bm7lt6ivd0p 2kr9co
28 Apr 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
zlkol
27 Jan 22
Entry into a Material Definitive Agreement
9:34pm
8-K
EX-10.1
wr9ddn978i vsiwp
19 May 21
Departure of Directors or Certain Officers
4:20pm
8-K
EX-99.1
elppo 3lxgpx2
10 Mar 21
Harvard Bioscience Announces Fourth Quarter 2020 Financial Results
7:00am
8-K
EX-10.1
1ze389tcku
23 Dec 20
Harvard Bioscience Announces New Credit Facility
5:15pm